EP3220916
Aðferð til meðferðar á krabbameini með N-((4,6-dímetýl-2-oxó-1,2-díhýdrópýridín-3-ýl)metýl)-5-(etýl(tetrahýdró-2H-pýran-4-ýl)amínó)-4-metýl-4'-(morfólínómetýl)[1,1'bífenýl]3karboxamíð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.11.2015EP published:
19.4.2023EP application number:
15860676.4
EP translation filed:
21.6.2023Grant published:
15.7.2023EPO information:
European Patent Register
Max expiry date:
16.11.2035Expiry date:
16.11.2026Next due date:
30.11.2026
Title in English:
METHOD FOR TREATING CANCER WITH N-((4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL(TETRAHYDRO-2H-PYRAN-4-YL) AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[1,1'-BIPHENYL]-3-CARBOXAMIDELanguage of the patent:
English
Timeline
Today
17.11.2015EP application
19.4.2023EP Publication
21.6.2023Translation submitted
15.7.2023Registration published
16.11.2026Expires
Owner
Name:
Epizyme, Inc.Address:
400 Technology Square, 4th Floor, Cambridge, MA 02139, US
Name:
Eisai R&D Management Co., Ltd.Address:
6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, JP
Inventor
Name:
KEILHACK, HeikeAddress:
Belmont, MA 02478, US
Name:
TRUITT, BrettAddress:
Cambridge, MA 02139, US
Name:
SUZUKI, YutaAddress:
Tokyo 112-8088, JP
Name:
MURASE, TsukasaAddress:
Tokyo 112-8088, JP
Name:
SHIKATA, FutoshiAddress:
Tokyo 112-8088, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462080985 PDate:
17.11.2014Country:
US
Number:
201562166572 PDate:
26.5.2015Country:
US
Number:
201562251903 PDate:
6.11.2015Country:
US
Classification
Categories:
A61K 31/5377, A61P 35/00, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.11.2023
Expires: 16.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.11.2023
Expires: 16.11.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.10.2024
Expires: 16.11.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.11.2025
Expires: 16.11.2026
Payer: Árnason Faktor ehf.